Remimazolam is a new ultrashort-acting benzodiazepine that acts on the γ-aminobutyric acid receptor. Remimazolam is rapidly hydrolyzed into inactive carboxylic acid metabolite by esterase metabolism, and its metabolism is independent on liver and kidney function. It has a short half-life and is not affected by the infusion time. Long time infusion is not easy to accumulate and can be antagonized by flumazenil, which has less impact on hemodynamics and respiration. These characteristics make remimazolam an ideal sedative drug. In recent years, it has been used in painless diagnosis and treatment, sedation of ICU, and the induction and maintenance of general anesthesia, the prospects of application are board. This paper mainly reviews the mechanism of action, pharmacokinetics, the influence on organ function, and the research progress of clinical application, so as to provide a theoretical basis for its clinical application.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |